Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
In vitro activity of lefamulin against bacterial pathogens commonly causing acute bacterial skin and skin structure infections (ABSSSI) and bloodstream infections (BSI): global SENTRY surveillance 2016